Popular
Movements With Meaning: Reading the Pattern, Not the Label
CME/CEMovements With Meaning: Reading the Pattern, Not the Label
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CEMaking the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
CME/CEPrecision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
Harry Erba, MD, PhD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Rethinking Potassium Restriction in Chronic Kidney Disease Management
Clinician's RoundtableRethinking Potassium Restriction in Chronic Kidney Disease Management
Deborah Clegg, PhD
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME/CERethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
Programs
Recognizing the Mental Burden of Psoriasis
On the Frontlines of PsoriasisRecognizing the Mental Burden of Psoriasis
Mio Nakamura, MD, MS
Steve Jackson, PharmD
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CEChairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 3
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 3
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 4
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 4
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Psoriasis and Mental Health: Why Whole-Patient Care Matters
On the Frontlines of PsoriasisPsoriasis and Mental Health: Why Whole-Patient Care Matters
Steve Jackson, PharmD
Tau Therapies and Clinical Translation: Mechanistic Approaches
MinuteCE®Tau Therapies and Clinical Translation: Mechanistic Approaches
Dani Cabral, MD
Mohammed Q. Al-Sabbagh, MD
Clinical Practice
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CEChairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Kathleen N. Moore, MD, MS
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CEImproving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE
Samir Dalia, MD
Christopher Jurief
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CEFXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
Treatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
CardiologyTreatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
Andrew Patrick Ambrosy, MD, MPH
Doctors Lounge
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
The Convergence“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
Brian P. McDonough, MD, FAAFP
Kate Rouch
Rehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
MAPSChatsRehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
Matt Birnholz, MD
Dr. Susanna Gallani
Navigating Vaccine Communication: A Medical Affairs Perspective
MAPSChatsNavigating Vaccine Communication: A Medical Affairs Perspective
Matt Birnholz, MD
Abigail Sporer, PhD, MBA
Designing Smarter Insight Frameworks in Medical Affairs
MAPSChatsDesigning Smarter Insight Frameworks in Medical Affairs
Matt Birnholz, MD
Tony Page
"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
The Convergence"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
CME
Movements With Meaning: Reading the Pattern, Not the Label
CME/CEMovements With Meaning: Reading the Pattern, Not the Label
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual EventPrecision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
MinuteCE®Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Adam J. Luginbuhl, MD
- NEW EPISODE
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
- NEW EPISODE
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
- NEW EPISODE
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
MinuteCE®SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
Industry Feature
Depression from Case to Clinic: Rethinking Partial Response with a Different Approach
Medical Industry FeatureDepression from Case to Clinic: Rethinking Partial Response with a Different Approach
Ashley Baker, MSN, PMHNP
Kimberly Giberga, MSN, APRN, FNP-C, PMHNP-BC
Bradford Perkins, MD
Improving Preterm Birth Outcomes with Virtual Cervix Technology
Medical Industry FeatureImproving Preterm Birth Outcomes with Virtual Cervix Technology
Mirella Mourad, M.D.
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Sarah Sammons, MD
Expanding Treatment Options in PNH: Expert Approaches to Personalized Care
Medical Industry FeatureExpanding Treatment Options in PNH: Expert Approaches to Personalized Care
Caroline Piatek, MD
Bhumika Patel, MD
Long-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
Medical Industry FeatureLong-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
Arati Chand, MD
Bhumika Patel, MD
Is It Time to Rethink How We Support Depression Management?
Medical Industry FeatureIs It Time to Rethink How We Support Depression Management?
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
Gustavo Alva, MD, DFAPA